PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 34954711-9 2022 Moreover, the memory-improving doses of agmatine augmented Akt/GSK-3beta pathway. Agmatine 40-48 thymoma viral proto-oncogene 1 Mus musculus 59-62 23154244-7 2013 Western blotting revealed that agmatine treatment significantly induced vascular endothelial growth factor (VEGF), VEGF receptor 2 (Flk-1/KDR or VEGFR2), phosphatidylinositol 3-kinase (PI3K), Akt/protein kinase B (also known as PKB, PI3K downstream effector protein), endothelial nitric oxide synthase (eNOS) nitric oxide (NO; product by eNOS) and intercellular adhesion molecule 1 (ICAM-1) expressions during bEnd.3 cells migration. Agmatine 31-39 thymoma viral proto-oncogene 1 Mus musculus 192-195 23154244-7 2013 Western blotting revealed that agmatine treatment significantly induced vascular endothelial growth factor (VEGF), VEGF receptor 2 (Flk-1/KDR or VEGFR2), phosphatidylinositol 3-kinase (PI3K), Akt/protein kinase B (also known as PKB, PI3K downstream effector protein), endothelial nitric oxide synthase (eNOS) nitric oxide (NO; product by eNOS) and intercellular adhesion molecule 1 (ICAM-1) expressions during bEnd.3 cells migration. Agmatine 31-39 thymoma viral proto-oncogene 1 Mus musculus 228-231 23154244-9 2013 SIGNIFICANCE: Taken together, we provide the first evidence that activation of VEGF/VEGFR2 and the consequential PI3K/Akt/eNOS/NO/ICAM-1 signaling pathways are serial events, through which the treatment of agmatine could lead to bEnd.3 cells migration. Agmatine 206-214 thymoma viral proto-oncogene 1 Mus musculus 118-121 29763645-9 2018 A 24 h co-incubation with subthreshold concentrations of ketamine (0.01 muM) and agmatine (0.001 muM) was able to cause a significant increase in the phosphorylation levels of Akt (Ser473) and p70S6 kinase (Thr389) as well as PSD95 immunocontent. Agmatine 81-89 thymoma viral proto-oncogene 1 Mus musculus 176-179 27685463-0 2016 Agmatine Reduces Lipopolysaccharide-Mediated Oxidant Response via Activating PI3K/Akt Pathway and Up-Regulating Nrf2 and HO-1 Expression in Macrophages. Agmatine 0-8 thymoma viral proto-oncogene 1 Mus musculus 82-85 27685463-7 2016 We further demonstrated that the agmatine-induced activation of Nrf2 is likely through the PI3K/Akt pathway. Agmatine 33-41 thymoma viral proto-oncogene 1 Mus musculus 96-99 27685463-8 2016 LY294002, a specific PI3K/Akt inhibitor, abolished agmatine-induced HO-1 up-regulation and ROS suppression significantly. Agmatine 51-59 thymoma viral proto-oncogene 1 Mus musculus 26-29 27685463-11 2016 Taken together, our findings revealed that agmatine has antioxidant activity against LPS-induced ROS accumulation in RAW 264.7 cells involving HO-1 expression induced by Nrf2 via PI3K/Akt pathway activation. Agmatine 43-51 thymoma viral proto-oncogene 1 Mus musculus 184-187